BHCM
RVNC

Brevan Howard Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Brevan Howard Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-522,716
Closed -$2.71M – 1469
2024
Q3 		$2.71M Buy
522,716
+483,448
+1,231% +$2.51M 0.02% 167
2024
Q2 		$101K Buy
+39,268
New +$101K ﹤0.01% 917
2024
Q1 		– Sell
-27,111
Closed -$238K – 1361
2023
Q4 		$238K Buy
+27,111
New +$238K ﹤0.01% 767